The level and pattern of in vitro activated expression of CD69, BTLA, and CTLA-4 indicate not only hyporesponsiveness of PB lymphocytes from CLL patients, primarily T cells, but also their exhausted phenotype. This evidence concerns the gene CD69 and B-cell chronic lymphocytic leukemia.